PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
*To whom correspondence should be addressed. E-mail: JJohnson1@cdc.gov
Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America
GlaxoSmithKline, Stevenage, United Kingdom
National HIV and Retrovirology Laboratories, Public Health Agency of Canada, Ottawa, Ontario, Canada
Post a new comment
on this article